Hawkeye Systems hires new CFO expects the release of 10k this week

New CFO has tremendous experience with startups and public accounting.

SAVANNAH, Ga., Jan. 21, 2021 — Hawkeye Systems, Inc. (OTCQB: HWKE), a technology holding company focused on pandemic management products and services, announced today it had hired Chris Mulgrew to serve as CFO permanently for the company.

Corby Marshall, CEO of Hawkeye, stated, “I am pleased to welcome someone with the experience and commitment of Chris to join our team and help us gain a much better handle on the timing of our filings and improve our ability to move quickly and accurately in our filings and as a public company.  Chris’s addition and the acquisition of IKON are synergistic growth drivers for the business to grow and thrive in 2021”

Mr. Mulgrew brings twenty plus years of senior-level finance, business development, and operations experience to Hawkeye Systems.  He recently served as Chief Financial Officer for an emerging oilfield service company and Strategic Advisor to a highly acquisitive SaaS company, both leading private equity-backed firms. In these roles, Christopher was instrumental in driving revenue growth, scaling finance and operations, and realizing synergies through strategic acquisitions. Over the course of Mr. Mulgrew’s career, he has held various leadership roles with successful high-growth companies, including the Shell Technology Ventures Fund and Pacific Western Brewing. Mr. Mulgrew earned an MBA from the top-ranked Jones Graduate School of Business at Rice University and a BBA in Accounting from Simon Fraser University in Canada.  Christopher is also qualified as a Chartered Public Accountant in Canada and a Certified Public Accountant in the US and has completed executive programs at the London School of Business. 

Mr. Mulgrew stated, “I am honored to be working with Corby and the entire Hawkeye Systems team to accelerate growth and deliver value for all stakeholders.” 

About Hawkeye Systems, Inc.
Hawkeye Systems, Inc. is a technology holding company focused on pandemic management products and services. The company is committed to leveraging its extensive resources supporting its ongoing mission to help our government and medical infrastructure keep civilians safe.

Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the PPE products and sales, the potential success of the company, our growth strategy and product development including that of other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

For more information, please contact:
Corby Marshall, CEO
Number: +1(800)531-8799
Email: pr@hawkeyesystemsinc.com
Website: hawkeyesystemsinc.com
Investor relations: ir@hawkeyesystemsinc.com

Hawkeye Systems Announces Letter of Intent to Acquire IKON Supplies

– Significant revenue increase is expected as Company continues its growth trajectory

SAVANNAH, Ga., Dec. 16, 2020 — Hawkeye Systems, Inc. (OTCQB: HWKE) (“Company”), a technology holding company focused on pandemic management products and services, is pleased to announce today it has signed a Letter of Intent (LOI) to acquire IKON Supplies, an FDA and CDC registered global trading company specializing in Personal Protective Equipment (PPE) supply chain management.

Corby Marshall, CEO of Hawkeye Systems, stated, “Over the past year, we have worked closely with IKON management as partners on a variety of successful procurement transactions. During this time, we witnessed firsthand the power of their supply chain relationships combined with their significant ability to drive and sustain long-term growth, evidenced by IKON’s multiple long-term supply contracts expected to drive exponential value for Hawkeye upon consolidation in Q1 2021.  We look forward to adding notable industry-leading management as we continue our focus on realizing long-term shareholder appreciation.”

CEO of IKON Supplies, Johnny Thomas, added, “This is a transformational moment for the health care industry, with new realities in a COVID-19 world that require decisive and concrete supply chain management and direct to factory relationships. We are excited to formalize our union with an established reputable PPE provider in Hawkeye over the coming weeks, forming a seasoned management team with a collective history of building trailblazing companies across a wide spectrum of industries. We believe this partnership will solidify the consolidated Company as a premier provider of PPE equipment catering to all industry verticals.”

Upon completion of the acquisition, Hawkeye will acquire a 51% interest of all equity of Ikon Supplies LLC and an option to purchase the remaining 49% interest. This LOI is non-binding and subject to a definitive agreement, which will be negotiated in good faith in the next 30 days. Ikon financials are currently unaudited and expected to be audited in Q1 2021.

About Hawkeye Systems, Inc.

Hawkeye Systems, Inc. is a technology holding company focused on cutting edge technology, pandemic management products, and services. The Company is committed to leveraging its extensive resources to support its ongoing mission to help our government and medical infrastructure keep civilians safe.

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the body camera system, the potential success of the body camera system, our growth strategy and product development including PPE, any technology related to our sales pipeline, and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition, and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

For more information, please contact:

Corby Marshall
CEO
Number: +1 (800) 531-8799
Email: info@hawkeyesystemsinc.com 
Website: hawkeyesystemsinc.com 
Investor relations –  ir@hawkeyesystemsinc.com

Hawkeye Systems Announces Letter of Intent to Secure Three-Year FDA Approved Nitrile Glove Supply

SAVANNAH, Ga., Nov. 12, 2020 — Hawkeye Systems, Inc. (OTCQB: HWKE)(“Company”), a technology holding company focused on pandemic management products and services, is pleased to announce today it has signed a Letter of Intent (LOI) with Whistler International Korea, a leading multinational conglomerate located in Seoul with operations in Asia, Middle East and Latin American Countries. Under the terms of the LOI, the Company is expected to secure a three-year FDA approved Nitrile glove supply comprised of 3,600,000 boxes annually.   

Corby Marshall, CEO of Hawkeye Systems, stated, “We are pleased to continue positioning the Company to procure dedicated supply sources of mission critical PPE (Personal Protective Equipment) as the number of COVID-19 positive cases continues to resurge in the US. We believe our LOI with Whistler to provide highly coveted Nitrile protective gloves further validates Hawkeye as a reliable PPE source with an established track record that already includes the previously announced procurement and delivery of FDA approved hand sanitizer and N95 protective masks. We value the process of safety and are honored to leverage our ability to navigate both international and domestic trade lines to strengthen our Country’s pandemic response.”

About Hawkeye Systems, Inc.

Hawkeye Systems, Inc. is a technology holding company focused on cutting edge technology, pandemic management products and services. The Company is committed to leveraging its extensive resources in support of its ongoing mission to help our government and medical infrastructure keep civilians safe.

For more information, please contact:
Corby Marshall, CEO
Number: +1 (800) 531-8799
Email: info@hawkeyesystemsinc.com 
Website: hawkeyesystemsinc.com 
Investor relations –  ir@hawkeyesystemsinc.com

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the body camera system, the potential success of the body camera system, our growth strategy and product development including PPE, any technology related to our sales pipeline, and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Hawkeye Manufacturing Partner DemeTECH Ramps Up Production

Hawkeye Systems manufacturing partner DemeTECH, the Only High-quality N95 & PPE Manufacturer in State of Florida, Ramps up Production And Adds 500 Jobs as the CDC Touts Mask Wearing as More Effective Than a Vaccine.

“As a US medical device manufacturer, but more importantly as Americans, we felt compelled to assist in any way we could during this devastating global pandemic,” says Luis Arguello Jr., Vice President of DemeTECH. “We are proud to be producing American-made surgical masks and now, NIOSH-approved N95 respirators, and the only facility to do so in Florida. We have greatly expanded our production and staffing to meet the demands that COVID-19 has placed on our heroes in the medical community.”

Since pivoting the company’s capability to create masks, DemeTECH has added 500 new jobs in Miami and obtained two additional production facilities to expand growth to address PPE production needs. The company anticipates adding another 600 jobs by the end of 2020, driving the local Miami economy further. Mr. Arguello adds “We at DemeTECH are on a mission to make what Americans need in America. We need to rebuild our country, starting with our healthcare industry, and be self-sufficient on products that protect our people and our children.”

Full release can be viewed at PR Newswire

Hawkeye Systems Provides Update on DemeTECH Partnership and Announces NIOSH Approval for US Made N95 Protective Masks

SAVANNAH, Ga., Oct. 8, 2020 — Hawkeye Systems, Inc. (OTCQB: HWKE) (“Company”), a technology holding company focused on pandemic management products and services, is pleased to announce today its manufacturing partner DemeTECH has been granted NIOSH certification for its line of US manufactured N95 Masks for which Hawkeye has secured guaranteed, uninterrupted production capacity on dedicated production lines.

Corby Marshall, CEO of Hawkeye Systems, stated, “NIOSH approval represents an enormous validation for our partnership with DemeTECH, an award-winning suture and medical device manufacturer with a superb industry reputation and vast experience distributing its products to over 130 countries. We believe we are now uniquely positioned to leverage a distinct competitive advantage over cheaper foreign manufacturers facing significant logistical and customs challenges in the post COVID-19 world. We look forward to expanding our partnership with DemeTECH as we remain focused on supporting the US pandemic response in conjunction with building long-term shareholder value.”

Luis Arguello Sr., President and CEO of DemeTECH, commented, “From our engineers to our quality control personnel, all aspects of our business have delivered extraordinary results and accomplishments in order to facilitate this certification in such a short period of time. We look forward to continuing to be a leader in providing USA made PPE products with Hawkeye Systems.”

N95 masks are the most common of the seven types of particulate filtering facepiece respirators. The product filters a minimum of 95% of all airborne particulate matter. NIOSH approval, designated by the National Institute for Occupational Safety and Health, is considered the gold standard of N95 masks and is provided only after a thorough vetting process to validate efficacy and quality of the resultant product.

About DemeTECH

Headquartered in Miami, Florida, DemeTECH, is a world-renowned leader in surgical sutures, mesh, bone wax, and recently expanded into PPE production, specifically Surgical masks and N95 respirators. DemeTECH strives to enhance doctor-patient relationships through hard work, dedication and a commitment to the pursuance of cutting-edge technology and innovation. DemeTECH’s NIOSH approved N95 masks are made in the USA with American raw materials.

For more information, please visit: https://demetech.us

About Hawkeye Systems, Inc.

Hawkeye Systems, Inc. is a technology holding company focused on cutting edge technology, pandemic management products and services. The Company is committed to leveraging its extensive resources in support of its ongoing mission to help our government and medical infrastructure keep civilians safe.

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the body camera system, the potential success of the body camera system, our growth strategy and product development including PPE, any technology related to our sales pipeline, and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

For more information, please contact:
Corby Marshall, CEO
Number: +1 (800) 531-8799
Email: info@hawkeyesystemsinc.com
Website: hawkeyesystemsinc.com
Investor relations: ir@hawkeyesystemsinc.com

Hawkeye Systems Sanitizer Product Released by FDA for US Entry

Following completion of the FDA review process at US Customs, Kiil is released for distribution 

Savannah, GA – August 24, 2020 – Hawkeye Systems, Inc. (OTCQB: HWKE), a technology holding company focused on pandemic management products and services, announced today its sanitizer product Kiil was released from US Customs and Border Protection following a detailed review and testing by the Food and Drug Administration (FDA).  

Corby Marshall, CEO of Hawkeye stated, “Upon intensive review of product quality and packaging requirements we are pleased to announce our sanitizer product was released from US Customs by the FDA for distribution to major retail and online channels. We believe this represents a level of validation for our product that speaks to its ability to realize broad market acceptance as we continue our mission to support our country’s virus protection resources.”

The product will be distributed through various channels and partners within the United States.

About Hawkeye Systems, Inc.

Hawkeye Systems, Inc. is a technology holding company focused on pandemic management products and services. The company is committed to leveraging its extensive resources in support of its ongoing mission to help our government and medical infrastructure keep civilians safe.

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the PPE products and sales, the potential success of the company, our growth strategy and product development including that of other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

For more information, please contact:

Corby Marshall, CEO
Number: +1(800)531-8799
Email: pr@hawkeyesystemsinc.com
Website: hawkeyesystemsinc.com

Investor relations: ir@hawkeyesystemsinc.com

Hawkeye Systems U.S.-Manufactured Masks Exceed 99% Filtration in ASTM Tests

SAVANNAH, Georgia, Aug. 17, 2020 — Hawkeye Systems, Inc. (OTCQB: HWKE), a technology holding company focused on pandemic management products and services, is pleased to announce an update on the progress of its partnership with DemeTECH, a U.S.-based manufacturer of suture and other medical devices and products. “In this partnership we started with the creation of a surgical mask first, which has tested out as a level three ASTM mask, and once we (DemeTECH) got FDA approval for that mask, then turned to n95s which have been submitted for NIOSH approval,” said Luis Arguello, Jr, SVP DemeTECH.

Hawkeye Systems Chief Executive Officer, Corby Marshall, stated, “The recent testing data gives us great confidence in the quality and efficacy of the masks being manufactured by our partner DemeTECH.  We are excited to expand the relationship and we have submitted samples for NIOSH certification.  We hope for improvement in the country’s challenges regarding the current Pandemic but are prepared to bring supply which does not require manufacture in a foreign country, which won’t have to go through the complications of logistics and customs during a pandemic, and which can ship daily from Miami. The United States dependency on foreign countries for continued PPE supplies is a business problem we are trying to become a major player in solving.”

For more information visit us at www.hawkeyesystemsinc.com

About Hawkeye Systems, Inc.

Hawkeye Systems, Inc. is a technology holding company focused on cutting edge technology, pandemic management products and services. The Company is committed to leveraging its extensive resources in support of its ongoing mission to help our government and medical infrastructure keep civilians safe.

About DemeTECH

Headquartered in Miami, Florida, DemeTECH, is a world-renowned leader in surgical sutures, mesh and bone wax. DemeTECH strives to enhance doctor-patient relationships through hard work, dedication and a commitment to the pursuance of cutting-edge technology and innovation. DemeTECH’s N95 masks are made in the USA with American materials. 

For more information, please visit: https://demetech.us 

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the PPE products and sales, the potential success of the company, our growth strategy and product development including that of other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

For more information, please contact:

Corby Marshall, CEO
Number: +1(800)531-8799
Email: pr@hawkeyesystemsinc.com
Website: hawkeyesystemsinc.com

Investor relations: ir@hawkeyesystemsinc.com

SOURCE Hawkeye Systems, Inc.

Related Links

https://demetech.us

Hawkeye Systems Announces Partnership With DemeTECH for Exclusive Rights to American Made N95 Protective Masks

Agreement includes up to three million masks per month with an option to expand production

SAVANNAH, Georgia, June 23, 2020 — Hawkeye Systems, Inc. (OTCQB: HWKE) (“Company”), a technology holding company focused on pandemic management products and services, is pleased to announce a partnership with DemeTECH, a world-renowned leader in surgical sutures, mesh and bone wax.

Corby Marshall, CEO of Hawkeye Systems, stated, “We are extraordinarily pleased to partner with a global healthcare leader in DemeTECH, an award-winning suture and medical device manufacturer with a superb industry reputation and vast experience distributing its products to over 130 countries.  As we continue to bolster our end user network, the Company is confident it can expand this opportunity to deliver American made masks beyond initial expectations while helping to refine our country’s pandemic response process.”

Luis Arguello Sr, President and CEO of DemeTECH, commented, “Evolving our manufacturing capabilities to accommodate the profound need for American made protective masks was a natural progression. Further, we are excited to be aligning with Hawkeye given their unique position in the burgeoning PPE (Personal Protective Equipment) landscape as we approach the review process for attaining the highly-coveted NIOSH approval.”

Under the terms of the Agreement, Hawkeye Systems has attained the right to DemeTECH production of up to 3,000,000 N95 protective masks per month, as well as an option for additional production for a period of up to 5 years.

N95 masks are the most common of the seven types of particulate filtering facepiece respirators. The product filters at least 95% of airborne particulate matter. NIOSH approval, designated by the National Institute for Occupational Safety and Health, is expected to be earned by DemeTECH within sixty days.

About DemeTECH

Headquartered in Miami, Florida, DemeTECH, is a world-renowned leader in surgical sutures, mesh and bone wax. DemeTECH strives to enhance doctor-patient relationships through hard work, dedication and a commitment to the pursuance of cutting-edge technology and innovation. DemeTECH’s N95 masks are made in the USA with American materials.

For more information, please visit: https://demetech.us 

About Hawkeye Systems, Inc.

Hawkeye Systems, Inc. is a technology holding company focused on cutting edge technology, pandemic management products and services. The Company is committed to leveraging its extensive resources in support of its ongoing mission to help our government and medical infrastructure keep civilians safe.

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the body camera system, the potential success of the body camera system, our growth strategy and product development including that of the body camera system, acquisition of Radiant Images, and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

For more information, please contact:

Corby Marshall, CEO
Number: +1(800)531-8799
Email: info@hawkeyesystemsinc.com 
Website: hawkeyesystemsinc.com  
Investor relations –  ir@hawkeyesystemsinc.com

Hawkeye Systems and Ikon Supplies Form Joint Venture to Develop, Market and Sell Personal Protective Equipment

Demand for Pandemic Management Products Continues to Increase

SAVANNAH, Georgia, June 11, 2020 — Hawkeye Systems, Inc. (OTCQB: HWKE), a technology holding company focused on pandemic management products and services, is pleased to announce its joint venture partnership with Ikon Supplies, of New York City. The joint venture will develop, market and sell various Personal Protective Equipment (“PPE”), including masks, gloves, gowns and sanitizer.

Hawkeye Systems is responsible for developing and providing any technology surrounding the bio-surveillance, anti-viral masks or other technology related aspects.

Ikon is responsible for providing current best practices for sourcing, funding and distributing PPE in conjunction with Hawkeye and will create a go to market plan collaboratively with Hawkeye Systems.

Corby Marshall, CEO of Hawkeye stated, “We are thrilled to partner with Ikon Supplies to develop, market and sell various PPE. We continue to see new opportunities and partners to accelerate our growth with our pandemic management products and services business. We look forward to working with Ikon in being able to provide critical safety protection and equipment to commercial businesses and individuals.”

About Hawkeye Systems, Inc.

Hawkeye Systems, Inc. is a technology holding company focused on cutting edge technology, pandemic management products and services. The Company is committed to leveraging its extensive resources in support of its ongoing mission to help our government and medical infrastructure keep civilians safe.

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the body camera system, the potential success of the body camera system, our growth strategy and product development including that of the body camera system, acquisition of Radiant Images, and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

For more information, please contact:
Corby Marshall, CEO
Number: +1 (800) 531-8799
Email: info@hawkeyesystemsinc.com 
Website: hawkeyesystemsinc.com
Investor relations –  ir@hawkeyesystemsinc.com

SOURCE Hawkeye Systems, Inc.

Hawkeye Systems Announces Letter of Intent With Jealous Devil to Distribute FDA-Approved Hand Sanitizer

Company will leverage exclusive North American license, reach major retail channels

SAVANNAH, Georgia, June 8, 2020 — Hawkeye Systems, Inc. (OTCQB: HWKE), a technology holding company focused on pandemic management products and services, announced today the execution of a letter of intent with legacy brand Jealous Devil to distribute its FDA-approved hand sanitizer, Kiil, exclusively across North America and through major retail channels including Amazon and US foods.

Corby Marshall, CEO of Hawkeye Systems, stated, “We are pleased to advance our growth initiatives while addressing the ongoing demand for pandemic management products and services, specifically FDA-approved hand sanitizer. In conjunction with distribution to our expansive end-user network seeking PPE (Personal Protective Equipment) supplies, management expects to continue securing new revenue opportunities that directly strengthen our PPE foothold, while strategically building long-term shareholder value.”

Under the terms of the joint venture agreement, Jealous Devil will provide Hawkeye logistics support and distribution of Kiil, specifically formulated with natural ingredients to kill Covid-19 other bacteria and viruses, through its established major retail channels. 

For additional information on Jealous Devil, please visit: https://jealousdevil.com

About Hawkeye Systems, Inc.

Hawkeye Systems, Inc. is a technology holding company focused on cutting edge technology, andemic management products and services. The Company is committed to leveraging its extensive resources in support of its ongoing mission to help our government and medical infrastructure keep civilians safe.

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the PPE products and sales, the potential success of the company, our growth strategy and product development including that of other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

For more information, please contact:

Corby Marshall, CEO
Number: +1 (800) 531-8799
Email: info@hawkeyesystemsinc.com 
Website: hawkeyesystemsinc.com 
Investor relations –  ir@hawkeyesystemsinc.com

SOURCE Hawkeye Systems, Inc.